ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 225,80
0,20%
Dow Jones
39 558,11
0,32%
DAX
18 716,42
-0,12%
Brent Oil
82,55
-0,79%
Bitcoin
61 533,30
-2,18%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Iovance Biotherapeutics Inc (IOVA)

  7. Iovance Biotherapeutics Inc (IOVA) Actualités

IOVA Iovance Biotherapeutics Inc

10,73
-0,15 (-1,38%)
Après les heures de négociation
Dernière mise à jour : 01:16:56
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Iovance Biotherapeutics Inc IOVA NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
-0,15 -1,38% 10,73 01:16:56
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
10,92 10,64 11,18 10,72 10,88
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
09/5/202423:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/5/202422:06EDGAR2Form 8-K - Current report
09/5/202422:01GLOBEIovance Biotherapeutics Reports First Quarter 2024 Financial..
01/5/202412:01GLOBEIovance Biotherapeutics to Host First Quarter 2024 Financial..
30/4/202412:01GLOBEIovance Biotherapeutics to Present at Upcoming Conferences
24/4/202422:01GLOBEIovance Biotherapeutics to Present Clinical and..
19/4/202423:15GLOBEIovance Biotherapeutics Reports Inducement Grants under..
22/3/202422:30GLOBEIovance Biotherapeutics Reports Inducement Grants under..
07/3/202400:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202423:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202423:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202423:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202423:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202423:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202423:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202414:00EDGAR2Form 8-K - Current report
04/3/202412:30GLOBEIovance Biotherapeutics Announces FDA has Lifted Clinical..
01/3/202423:00GLOBEIovance Biotherapeutics to Present at Upcoming Conferences
29/2/202413:30EDGAR2Form 8-K - Current report
28/2/202422:05EDGAR2Form 8-K - Current report
28/2/202422:01GLOBEIovance Biotherapeutics Reports Fourth Quarter and Full Year..
22/2/202422:53EDGAR2Form 8-K - Current report
22/2/202414:45GLOBEIovance Biotherapeutics to Host Fourth Quarter and Full-Year..
21/2/202422:44EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
20/2/202423:23EDGAR2Form 8-K - Current report
20/2/202422:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/2/202412:30GLOBEIovance Biotherapeutics, Inc. Announces Pricing of $211..
20/2/202412:03EDGAR2Form 8-K - Current report
16/2/202423:30GLOBEIovance Biotherapeutics Reports Inducement Grants under..
16/2/202421:38GLOBEIovance Biotherapeutics to Host Conference Call and Webcast..
16/2/202421:19GLOBEIovance’s AMTAGVI™ (lifileucel) Receives U.S. FDA..
14/2/202412:16EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
19/1/202423:15GLOBEIovance Biotherapeutics Reports Inducement Grants under..
19/1/202400:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202400:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202400:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202423:03EDGAR2Form 8-K - Current report
28/12/202313:27IHMARKETNEWSWall Street Highlights: Amazon to Introduce Ads on Prime..
27/12/202323:00EDGAR2Form 8-K - Current report
27/12/202313:54DJNIovance Shares Fall Premarket As FDA Places Study On Hold..
27/12/202313:00GLOBEIovance Biotherapeutics Announces Clinical Program Update..
22/12/202323:15GLOBEIovance Biotherapeutics Reports Inducement Grants under..
17/11/202323:00GLOBEIovance Biotherapeutics Reports Inducement Grants under..
07/11/202323:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202322:05EDGAR2Form 8-K - Current report
07/11/202322:01GLOBEIovance Biotherapeutics Reports Third Quarter and..
31/10/202321:01GLOBEIovance Biotherapeutics to Host Third Quarter and..
31/10/202314:05GLOBEIovance Biotherapeutics to Present Clinical and Pre-Clinical..
20/10/202323:15GLOBEIovance Biotherapeutics Reports Inducement Grants under..
19/10/202302:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Dernières Valeurs Consultées

NASDAQ
IOVA
Iovance Biotherapeutics
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés